# Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males

> **NCT00930215** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** D961H
- **DRUG:** D961H

## Key facts

- **NCT ID:** NCT00930215
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** —
- **Final completion:** 2009-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2009-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00930215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00930215, "Study Comparing Gelatine Capsule 40 mg D961H and HPMC Capsule in Japanese Healthy Males". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00930215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*